21 matches for your search in the start-up spotlight
rss
Cambridge-based TRIMTECH Therapeutic’s mission is to create novel small molecule degraders of protein aggregates that will combat neurodegenerative and inflammatory diseases including Alzheimer’s disease, a leading cause of death globally. The Company’s proprietary degrader technology is focused ...
Abselion started in 2018, at that time under the name HexagonFab, in a small corner of a laboratory at the University of Cambridge. We set out with the humble goal to make protein research simpler. Scientists should be able to pursue their passion for discovery and innovation, rather than spend ...
Together, we stand at the brink of a journey, charging forth to redefine energy. Systems-level innovation, born from a decade of shared dedication between world-class technicians, scientists, and experts. We believe in a collaborative approach to innovation and a systems-level approach to ...
Mogrify has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and ...
DIOSynVax customises vaccine antigen design to maximise the protection that vaccines can provide worldwide against existing and future viruses. Grounded firmly in virus structure and evolution, our method is patent protected, combining computational biology with in vitro and in vivo validation, ...
Broken String Biosciences is a genomics company with the goal of developing safer cell and gene therapies by assessing the stability of the genome. The Company is building a technology platform pipeline that will drive the development of cell and gene therapies that are safer by design. Its core ...
Camena Bioscience is a synthetic biology company with novel DNA synthesis technology. Built on over 7 years of innovation and with deep insight to the challenges faced in the pharmaceutical and biotechnology industries, their pioneering platform gSynth™ is rewriting the possibilities of DNA ...
Enhanc3D Genomics was spun out from the laboratories of Dr. Stefan Schoenfelder and Professor Peter Fraser, who pioneered research into the dynamic spatial organisation of the genome at the Babraham Institute in Cambridge, UK. Our mission is to unlock the full potential of the human genome’s 3D ...
Transine Therapeutics is developing a novel class of therapeutic RNAs that have the property to drive up protein expression with an unprecedented level of control and specificity: The SINEUP® platform. Our SINEUPs are designed to precisely bind to a target mRNA and boost expression of almost any ...
Evonetix is a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists’ ability to use biology on a scale not currently ...
